Call for Abstract

53rd World Congress on Microbiology, will be organized around the theme “Exploring Microbial Worlds: From Discovery to Application”

Microbiology 2024 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Microbiology 2024

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.


Ecology, Evolution and Biodiversity, formerly the Microbial Ecology and Evolution track encompasses many aspects of microbial and phage ecology and the roles of microbes in their natural environments. Our rapidly advancing knowledge of the complexity, immense diversity, and important roles of natural microbial communities will be highlighted in many of the exciting EEB sessions.



 



Agricultural Microbiology covers topics related to the role of microorganisms in the mobilization of nutrients for plant growth such as the relationship of microbial genetics and biological nitrogen; plant surface microflora and plant nutrition; developments in grass-bacteria associations; discusses the use of microorganisms in the management of pathogens, pests, and weeds and includes topics such as the microbial control of insect pests; microbial herbicides; and agricultural antibiotics. It also strategies in bioconversion such as the production of biogas from agricultural wastes; bioconversion of lignocelluloses into protein-rich food and feed; and ethanol fuel from biomass.



 



Plant Pathology outlines how to recognize, treat, and prevent plant diseases. It covers the wide spectrum of abioticfungalviralbacterialnematode and other plant diseases and their associated epidemiology. It also covers the genetics of resistance and modern management on plant disease.



 



Containing the latest information on  Pathogenesis and DiagnosisVeterinary Microbiology addresses both specific, defined problems, as well as trends in host/parasite interaction. This session is a complete reference on microbial biology, diseases, diagnosis, prevention, and control. Also, foundation of knowledge on pathogens and how they interact with hosts



 



We are in the era of speed and precision. Like many other disciplines in environmental biology, aquatic microbiology tends to move forward with new rapid and cutting edge tools to study water-related microorganisms from river banks to the abyss of the oceans. These innovations help to resolve the issues with determining the risks associated with climate change, human activities as well as the interactions between species to redefine what a healthy water environment is for all living organisms sharing these environments.



 



The track is organized into three thematic sessions: Soil MicrobiologyWater Microbiology, and Environmental Biotechnology. The first sessions includes researches on soil as a habitat for microorganisms, and introduces the main types of soil microorganisms, how they interact with the soil, and the techniques used in their analysis. In the second section includes Freshwater, Wastewater, and Drinking Water Microbiology and assays of microbial pathogens-bacteria, viruses, and protozoan parasites which are used in food and water quality control as well as an exercise in applied bioremediation of contaminants in water. Environmental Microbiology also includes the study of microorganisms that exist in artificial environments such as bioreactors.



Industrial microbiology is primarily associated with the commercial exploitation of microorganisms and involves processes and products that are of major economic, environmental and gregarious consequentiality throughout the world.



 



The focus is the host cell responses elicited by the interaction of micro-organisms. Equal emphasis is placed on responses to prokaryotic, viral and eukaryotic micro-organisms. In addition to mammalian systems, papers addressing other hosts such as plants and insects are strongly encourage. Systems biology is a rapidly expanding discipline fueled by the 'omics era and new technological advances that have increased the precision of data obtainable.



 



Molecular microbiology is a rapidly expanding area of contemporary science: the application of molecular biology has opened the microbial world in many remarkable ways. The attraction of microbes is that they are self-contained and that they offer complete solutions to understanding the phenomenon of life.



 


Bacteriology, Bacterial Pathogens and Associated disease will cover a range of important topics relevant Bacteria and its impact.  The latest information on Bacterial Pathogens and Associated diseases like Mycobacterium tuberculosis bacteria, Streptococcus and Pseudomonas, Shigella, Campylobacter, and Salmonella and others will be featured in this track.

 



This track focuses on cell structure and synthesis of cell components followed by detailed discussions of geneticsmetabolismgrowth, and regulation and mechanisms underlying cell survival and growth. This approaches the subject from a modern molecular genetic perspective, incorporating new insights gained from various genome projects.



Applied and Environmental Science (AES) is well-covered in the program of Microbiology 2024. The most exciting findings in this field in the last few years will be presented including recent, game-changing discoveries of microbial players and physiologies in the major BiogeochemicalCyclesMicrobial InteractionsElectromicrobiology and Syntheticmicrobiology.



 



Clinical and Public Health Microbiology (CPHM) has always been well-represented at Microbiology Conferences, Meetings and will continue to be so at Microbiology 2024. Thorough coverage of the science of antibiotic susceptibility testing: new protocols, new drug panels, new drugs in the pipeline, and new organisms to test are among the most important part of the track. Sessions in this track will also deep dive into testing and treatment of all clinically important microbe with growing incidence.



Clinical Infections and Vaccines (CIV)  will cover a range of important topics relevant to Infectious diseases and their impact on human health. The latest information on common healthcare-associated infections, such as Clostridium difficilePneumonia, and complicated urinary tract infections and others will be featured in this track. The science in this track works to bring together angstrom-level discovery and clinical research to reduce the burden of infectious diseases around the globe. 



Antimicrobial Agents and Resistance (AAR) will cover a range of important topics. One of the major challenges today is the rising tide of antimicrobial resistance, with the emergence of "untreatable" microbes causing diseases that were once readily treatable. The AAR track is the best place to find information regarding new antimicrobial agent discovery, preclinical investigations of new antimicrobial drugs in the pipeline, and first-look data of human clinical trials using new antimicrobial agents.



 



The track explores the etiologic agents of human disease belonging to the animal kingdom: protozoa, helminths (worms), and arthropods (insects and spiders), all of which are a significant cause of, or link to illness encountered both in tropical and temperate environments. In addition, it also deals with the clinical diseases they cause, their modes of acquisition, transmission and epidemiology, and their pathogenesis, diagnosis, treatment and prevention.



 



Virology, a subfield of microbiology or of medicine covering all aspects of new and reemerging viruses that cause severe and/or lethal diseases in humans and animals. Examples of these viruses include filoviruses (Ebola, Marburg), henipaviruses (Nipah, Hendra), Lassa virus, Lujo virus, South American hemorrhagic fever viruses (Junin, Machupo, Guanarito, Chapare, Sabia), Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, hantaviruses, SARS coronavirus, MERS coronavirus, tick-borne encephalitis viruses, and Zika virus.



 



 



This track focuses on the Spectrum of Fungi that infects Humans. In previously healthy individuals, invasive fungal disease is rare because animals’ sophisticated immune systems evolved in constant response to fungal challenges. In contrast, fungal diseases occur frequently in immunocompromised patients. Paradoxically, successes of modern medicine have put increasing numbers of patients at risk for invasive fungal infections.